Adcore Announces the Engagement of Bristol Capital and Dr. Reuter for Investor Relations Services

TORONTO, ONTARIO – March 13, 2023 – Adcore Inc. (the “Company” or “Adcore”) (TSX:ADCO) (OTCQX:ADCOF), a leading e-commerce advertising management and automation platform to leverage digital marketing in an effortless and accessible way (“Effortless Marketing”), today announced that it has retained Bristol Capital Ltd. (“Bristol”) and Dr. Reuter Investor Relations (“Dr. Reuter”) for investor relations services in North America and Europe, respectively. 

Bristol is a leading investor relations firm servicing Canadian and U.S. microcap and small cap companies across international markets providing investor relations and communication services. Dr. Reuter is a European investor relations agency that provides similar services into the European market.

Bristol has been engaged by the Company for an initial period of 12 months, which shall be renewed automatically for successive one-year periods thereafter unless terminated in accordance with the provisions of the agreement. Bristol will be paid a monthly fee of up to CAD $10,000, plus applicable taxes. In addition, the Company has agreed to grant Bristol an aggregate of 200,000 incentive stock options of the Company at an exercise price of CAD $0.35 per share for a period ending 36 months from the date of grant. Dr. Reuter has been engaged by the Company for an initial term of 6 months, which shall be renewed automatically for an additional 6-month period and afterwards one-month periods, unless terminated in accordance with the provisions of the agreement. Dr. Reuter will be paid a monthly fee of up to €3,000, plus applicable taxes. Neither Bristol nor Dr. Reuter nor its principals or affiliates have an interest, directly or indirectly in the Company or its securities and act at arm’s length to the Company.

The Company also announced that it terminated the engagement of IMS Investor Relations (“IMS”). IMS provided investor relations services to Adcore from January 1, 2021 to February 28, 2023.

Omri Brill, Adcore’s CEO commented: “We are excited to announce the engagement of Bristol Capital and Dr. Reuter for investor relations services in North America and Europe, respectively. As we continue to grow and expand our business, we recognize the importance of effective communication with our shareholders and the investment community. We are confident that Bristol and Dr. Reuter will provide us with the expertise and guidance necessary to enhance and reenergize our investor relations efforts, and we look forward to working with them. We would also like to take this opportunity to thank IMS Investor Relations for their services over the past two years. We appreciate their dedication and support during that time and wish them continued success in their future endeavors.”

Mr. Brill concluded: “At Adcore, we are committed to building a strong and transparent relationship with our shareholders and the investment community. We believe that our partnership with Bristol and Dr. Reuter will be an important part of achieving that important goal.”